LSD clinical trials: pipeline by phase and status
Every trial in this library's ClinicalTrials.gov slice that names LSD: 44 registered studies, grouped by phase and by recruitment status. For the published research, see the LSD research page.
The pipeline at a glance
| Phase | Trials |
|---|---|
| Early phase 1 | 8 |
| Phase 1 | 12 |
| Phase 1/2 | 2 |
| Phase 2 | 8 |
| Phase 3 | 1 |
| Not applicable | 8 |
| Unspecified | 5 |
| Status | Trials |
|---|---|
| Recruiting or planned | 13 |
| Active, not recruiting | 2 |
| Completed | 27 |
| Unknown or other | 2 |
2,391 participants across the 44 trials that report enrollment. The earliest registered start is 2007, and 12 trials started in the last two years.
Most active sponsors
- University Hospital, Basel, Switzerland 18 trials
- Northern Jiangsu People's Hospital 4 trials
- University of Chicago 3 trials
- Eleusis Therapeutics 2 trials
- Felix Mueller 2 trials
Evidence by condition
All 44 trials
Most advanced phase first, and within each phase the most recent start date first.
Phase 3 1 trial
-
Completed Phase 3 50 participants Centre Hospitalier Universitaire de Besancon Started 2020
Sodium Lactate, Intracranial Hypertension, Brain Relaxation
Phase 2 8 trials
-
Recruiting Phase 2 128 participants Felix Mueller Started 2026
Alcohol Use Disorder (AUD)
-
Recruiting Phase 2 65 participants Radboud University Medical Center Started 2025
Chronic Cluster Headache
-
Recruiting Phase 2 60 participants University Hospital, Basel, Switzerland Started 2024
Palliative Care, Pain, Anxiety, Depression
-
Completed Phase 2 198 participants Definium Therapeutics US, Inc. Started 2022
Anxiety Generalized
-
Completed Phase 2 60 participants University Hospital, Basel, Switzerland Started 2019
Major Depressive Disorder
-
Recruiting Phase 2 30 participants University Hospital, Basel, Switzerland Started 2019
Cluster Headache
-
Completed Phase 2 46 participants University Hospital, Basel, Switzerland Started 2017
Patients, Anxiety Disorders
-
Completed Phase 2 12 participants Multidisciplinary Association for Psychedelic Studies Started 2008
Anxiety
Phase 1/2 2 trials
-
Unknown status Phase 1/2 60 participants Maastricht University Started 2023
Prosocial Behavior
-
Completed Phase 1/2 10 participants Royan Institute Started 2007
Limbal Stem Cell Deficiency
Phase 1 12 trials
-
Not yet recruiting Phase 1 10 participants Johns Hopkins University Started 2026
Major Depression Moderate, Major Depression Severe, Major Depression
-
Recruiting Phase 1 24 participants University Hospital, Basel, Switzerland Started 2025
Healthy
-
Completed Phase 1 20 participants University Hospital, Basel, Switzerland Started 2024
Healthy
-
Completed Phase 1 24 participants University Hospital, Basel, Switzerland Started 2022
Healthy
-
Completed Phase 1 45 participants University of Fribourg Started 2022
Healthy
-
Completed Phase 1 20 participants University Hospital, Basel, Switzerland Started 2022
Healthy
-
Completed Phase 1 24 participants University Hospital, Basel, Switzerland Started 2021
Healthy
-
Completed Phase 1 24 participants University Hospital, Basel, Switzerland Started 2020
Healthy
-
Completed Phase 1 32 participants University Hospital, Basel, Switzerland Started 2020
Healthy
-
Completed Phase 1 80 participants University of Chicago Started 2018
Healthy
-
Completed Phase 1 32 participants Eleusis Therapeutics Started 2015
Healthy
-
Completed Phase 1 48 participants Eleusis Therapeutics Started 2015
Healthy Volunteers
Early phase 1 8 trials
-
Completed Early Phase 1 42 participants University of Chicago Started 2025
LSD
-
Completed Early Phase 1 41 participants University of Chicago Started 2025
LSD, Major Depressive Disorder, Depression
-
Active, not recruiting Early Phase 1 40 participants Copenhagen University Hospital, Rigshospitalet Started 2023
Basic Science
-
Completed Early Phase 1 28 participants University Hospital, Basel, Switzerland Started 2019
Healthy
-
Completed Early Phase 1 16 participants University Hospital, Basel, Switzerland Started 2017
Healthy
-
Completed Early Phase 1 28 participants University Hospital, Basel, Switzerland Started 2017
Healthy
-
Completed Early Phase 1 24 participants University Hospital, Basel, Switzerland Started 2014
Healthy
-
Completed Early Phase 1 16 participants University Hospital, Basel, Switzerland Started 2013
Healthy
Not applicable 8 trials
-
Recruiting 20 participants Northern Jiangsu People's Hospital Started 2026
Cirrhosis, Splenectomy, Portal Vein Thrombosis, Hypertension, Portal
-
Recruiting 24 participants University Hospital, Basel, Switzerland Started 2026
LSD Reaction
-
Not yet recruiting 150 participants Friederike Holze Started 2025
PMS, PMDD
-
Completed 30 participants University Hospital, Basel, Switzerland Started 2024
LSD Reaction
-
Enrolling by invitation 48 participants Felix Mueller Started 2022
Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD
-
Unknown status 150 participants Universidade do Porto Started 2022
Spondyloarthritis, Ankylosing Spondylitis
-
Completed 21 participants St. Olavs Hospital Started 2016
Depressive Disorder, Depressive Disorder, Major
-
Completed 25 participants Psychiatric University Hospital, Zurich Started 2015
Healthy
Unspecified 5 trials
-
Not yet recruiting 140 participants Northern Jiangsu People's Hospital Started 2026
Liver Cirrhosis
-
Not yet recruiting 30 participants Northern Jiangsu People's Hospital Started 2026
Cirrhosis, Liver, Splenectomy; Status, Renal Function Abnormal, Portal Hypertension
-
Not yet recruiting 30 participants Northern Jiangsu People's Hospital Started 2026
Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles
-
Completed 10 participants Tatiana Aboulafia Brakha Started 2024
Depression, Anxiety
-
Active, not recruiting 376 participants University Hospital, Geneva Started 2020
Major Depressive Disorder (MDD), Anxiety Disorders, Substance Use Disorder (SUD), PTSD - Post Traumatic Stress Disorder
Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.